XML 110 R95.htm IDEA: XBRL DOCUMENT v3.22.2.2
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenues $ 2,046 $ 2,111 $ 5,931 $ 6,238
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 942 941 2,670 2,775
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 462 469 1,369 1,393
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 402 409 1,177 1,115
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 220 269 655 884
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 20 23 60 71
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 544 527 1,509 1,515
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 543 525 1,508 1,509
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 1 2 1 6
International        
Disaggregation of Revenue [Line Items]        
Revenues 250 271 727 890
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 72 61 206 187
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 38 41 111 98
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 131 161 386 579
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 9 8 24 26
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 72 74 201 219
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 72 74 201 219
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0
Diversified Products        
Disaggregation of Revenue [Line Items]        
Revenues 238 290 722 850
Diversified Products | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 206 234 608 699
Diversified Products | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified Products | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 2 3 5 7
Diversified Products | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 24 47 91 125
Diversified Products | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 6 6 18 19
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 942 949 2,772 2,764
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 121 121 348 380
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 390 395 1,168 1,174
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 362 365 1,061 1,010
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 65 61 178 180
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 4 $ 7 $ 17 $ 20